Published in Cancer Weekly, January 29th, 1996
The results appear in the January 15, 1996, issue of The Journal of Clinical Investigation. In these in vivo studies, a team of academic and Medarex scientists led by Professor Jan G.J. van de Winkel of Utrecht University, developed transgenic mice whose white blood cells are genetically modified to express human Fc receptors; these modifications allow the mice to be used as a model system for testing the Bispecifics which have been developed by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.